CAMBRIDGE, Mass., March 13, 2025 — Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group (HKG:0806), one of Asia’s largest independent asset management firms, with strong participation from industry- and technology-focused new investors, as well as continued support from global existing backers.

The funds raised in this round will be directed to advance Insilico’s innovative drug pipeline and AI platform developments. On one side, resources will focus on refining AI models and algorithms, alongside updates and expansions to its state-of-the-art automatic lab to further automate and streamline R&D processes. On the other side, Insilico will focus on advancing the clinical validation of its flagship candidate for idiopathic pulmonary fibrosis treatment and accelerating the exploration of other independently developed and co-developed drug pipelines, driving impactful innovations in healthcare.

“We are excited to partner with Insilico Medicine in its mission to transform drug discovery with AI and automation. With a proven track record and a leadership position in AI-driven drug development, Insilico is at the forefront of transforming the industry. We believe that Insilico’s advancements will not only accelerate the development of life-saving therapies but also redefine the future of biopharmaceutical R&D. This partnership also marks a significant milestone for Value Partners’ private equity strategy and our vision of investing in disruptive innovations that have the potential to reshape industries,” said Dr. Chuen Yan Leung, Partner (Healthcare Investments).

“We are thrilled to announce our $110 million Series E financing—a key milestone that reflects our unwavering commitment to transforming healthcare and the strong confidence of our investors. This round, led by Value Partners and anchored by industry-focused investors, was heavily oversubscribed, drawing exceptional interest from prominent investors,” said Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine. “The funds raised will accelerate the advancement of our drug pipeline and AI platform, further solidifying Insilico’s leadership in this rapidly evolving sector. We remain dedicated to our mission of extending productive longevity to people and are proud to be at the forefront of innovation in healthcare.”

Since its previous financing round, Insilico has achieved substantial progress in both the development of AI platform and drug discovery pipeline and has showcased the ability of its proprietary AI-driven platform to significantly reduce costs and enhance efficiency in the early stages of drug discovery. As its announced key benchmarks for internal preclinical candidate (PCC) programs show: By integrating advanced AI and automation technologies, Insilico has reduced the average time to PCC nomination to just 12-18 months compared to traditional drug discovery methods (typically require 2.5-4 years) , while enabling the synthesis and testing of only 60-200 molecules per program.

Pharma.AI, the proprietary platform developed by Insilico, undergoes major updates twice a year to maintain its technological edge. Built around generative AI and continuously integrating cutting-edge technologies, Pharma.AI provides a comprehensive solution spanning biology, generative chemistry, clinical medicine, and scientific research. As the technology evolves, Insilico has further enhanced Pharma.AI by introducing innovative engines powered by large language models (LLMs), including Nach01, a multimodal foundation model for natural and chemical languages, and Dora, a multi-agent generative research assistant. Recently, Insilico deployed the first bipedal humanoid AI Scientist within Life Star1, its fully robotic lab connected to Pharma.AI, designed to further optimize and automate research workflows.

To date, Insilico has rapidly built a wholly-owned drug discovery portfolio of 30 assets driven by its advanced Pharma.AI platform, with 10 of these assets receiving IND clearance. Among them, the most advanced candidate, Rentosertib (formerly known as ISM001-055), developed for treating idiopathic pulmonary fibrosis (IPF), has progressed through multiple clinical studies with encouraging results. In a completed Phase IIa clinical trial, Rentosertib demonstrated favorable safety and tolerability across all dose levels, along with dose-dependent response in forced vital capacity (FVC), after only 12 weeks of dosage.

In addition, Insilico has established a sustainable revenue stream through its business model centered on out-licensing deals for its pipelines. The company has secured four pipeline out-licensing agreements with Fosun Pharma, Exelixis, and Menarini, collectively valued at over $2.1 billion. Concurrently, Insilico has initiated multiple drug discovery and development collaborations with industry partners, including Sanofi, Saudi Aramco, Therasid Bioscience and others, with the collected value of over $1.4 billion. Many of these partnerships have reached milestones, resulting in milestone payments to Insilico, further contributing to the company’s growing financial performance.

With the successful completion of its Series E financing, Insilico will further accelerate the advancement of AI-powered biopharmaceutical research and development, strengthen collaboration across the industry value chain, and drive the application of its cutting-edge AI platform in diverse scenarios within the life sciences sector through flagship use cases.

About Insilico Medicine

Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry, medicine and science research using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. For more information, please visit www.insilico.com.

About Value Partners Group Limited

Value Partners, one of Asia’s leading independent asset management firms, seeks to offer world-class investment services and products. Since its establishment in 1993, the Company has been a dedicated, specialist value investor in Greater China and Asia. In November 2007, Value Partners Group became the first asset management firm to be listed on the Main Board of the Hong Kong Stock Exchange (Stock code: 806 HK). In addition to its Hong Kong headquarters, the firm operates in Shanghai, Shenzhen, Singapore and London. Value Partners’ investment strategies cover equities, fixed income, multi-asset, alternatives, real estate and quantitative investment solutions, for institutional and individual clients in Asia Pacific, Europe and the United States. For more information, please visit www.valuepartners-group.com.

SOURCE Insilico Medicine

DENVER, March 13, 2025 — Konvoy, a leading venture capital firm specializing in gaming and interactive entertainment, has partnered with their portfolio company, Rocket Science, a premier technical services provider for game developers, to release the 2025 Game Developer Survey. This in-depth report compiles insights from 155 game developers, shedding light on the shifting landscape of game development, technology adoption, and monetization strategies. 

The report highlights a notable shift in game engine preferences, with Unity remaining a dominant force but seeing increased competition from open-source alternatives like Godot and Stride, particularly among smaller studios.

Artificial intelligence continues to play a role in game development, but enthusiasm for AI-generated content is cooling. While many studios experimented with generative AI in 2024, the report finds that developers are now focusing AI applications on workflow automation and backend efficiencies rather than creative content generation. 

The survey also uncovers major shifts in user acquisition and monetization strategies. Possibly due to changes in Apple’s pricing model, many studios are reducing their reliance on Apple Search Ads, turning instead to platforms like Tenjin and Branch for more cost-effective user acquisition solutions. 

In the multiplayer space, studios are reevaluating backend technology choices. Despite launching new product offerings, Photon has seen a decline in adoption, while Edgegap is gaining traction following its Epic Online Services partnership, signaling a growing preference for flexible and scalable multiplayer infrastructure solutions. 

To discuss these findings, Konvoy and Rocket Science hosted an exclusive industry panel on March 11th, featuring Karthik Bala (CEO, Velan Studios) and Mark James (CTO, Endava Games), moderated by Brian Corrigan (Co-Founder, Rocket Science) and Jackson Vaughan (Managing Partner, Konvoy Ventures). 

“This year’s survey confirms what we’ve been hearing from developers: the game development landscape is shifting faster than ever,” said Brian Corrigan, Co-Founder of Rocket Science. “From changes in preferred engines to evolving multiplayer infrastructure, the industry is undergoing a massive transformation. Understanding these trends is critical for developers navigating an increasingly complex ecosystem.”

The survey findings reflect a broader industry pivot. The rise of open-source engines highlights a demand for cost-effective and flexible development tools, particularly among independent studios. At the same time, developers are reassessing AI’s role in game creation, shifting their focus toward practical AI applications like QA automation and localization. With user acquisition and monetization strategies evolving rapidly, studios are adjusting their approaches to maximize engagement while controlling costs. 

“Partnering with Rocket Science allowed us to bring an incredibly deep level of technical expertise to our inaugural game developer survey,” said Jackson Vaughan, Managing Partner at Konvoy Ventures. “These insights help developers and industry leaders navigate an evolving landscape and make informed decisions about the tools and platforms shaping their businesses.” 

The full 2025 Game Developer Survey is now available. To access the report, please visit: (link https://www.konvoy.vc/reports/game-developer-survey-2025). 

About Konvoy:
Konvoy is a thesis driven venture capital firm. We invest in the platforms and technologies at the frontier of gaming.
Learn more at (https://www.konvoy.vc/) 

About Rocket Science:
Rocket Science Group builds top-tier studios that combine specialized expertise with operational excellence.
Learn more at (https://www.rocketscience.gg). 

SOURCE Konvoy

SAN JOSE, Calif., March 13, 2025 — PRE Security, the world’s first AI Native Predictive Security Operations (SecOps) company, has been recognized with multiple Cybersecurity Excellence Awards, further cementing its leadership in AI-driven security innovation. Among the prestigious honors, co-founder John “JP” Peterson has been named the AI Security Innovator of the Year for 2025.

AI Security Innovator of the Year: John “JP” Peterson
“With PRE Security being one of the pioneering companies leading cybersecurity into the AI era, it’s no surprise that John has been recognized as the AI Security Innovator of the Year,” said Paul Jespersen, co-founder of PRE Security. “JP has a proven track record of innovation, technical leadership, and transforming cutting-edge security product concepts into market-ready solutions—culminating in his work here at PRE Security.”

Holger Schulze, founder of Cybersecurity Insiders and organizer of the Cybersecurity Excellence Awards, extended his congratulations as well: “As we celebrate a decade of recognizing excellence in cybersecurity, we are proud to honor John Peterson for his innovation, commitment, and leadership. His contributions set a powerful example for the entire industry.”

Additional Cybersecurity Excellence Awards for PRE Security
Beyond Peterson’s individual recognition, PRE Security was also awarded in the following categories:

• Most Innovative Cybersecurity Company (10-49 Employees)
• Best AI SecOps Solution
• Excellence in Cybersecurity Innovation

“These awards validate our leadership in AI-driven cybersecurity, particularly in Generative and Agentic AI,” said Peterson. “Our patent-pending technologies, such as Parserless™ data ingestion and Next Alert Prediction, and our industry first CyberLLM™ are pushing SecOps into the future. While I am honored to receive the AI Security Innovator of the Year award, this recognition truly reflects the dedication and ingenuity of our entire PRE Security team.”

PRE Security’s Continued Growth and Leadership Expansion
PRE Security’s rapid growth has been fueled by significant product advancements and the growing world class team. To build on this momentum, the company has made key leadership appointments:

• Leo Versola has been promoted to Chief Product Officer, responsible for driving product vision and development.
• Jens Andreassen has joined as Vice President of International to help lead the expansion of our international teams. Prior to this, Andreassen served as Vice President of International at Fortinet and later as CEO of Lastline (which was acquired by VMware,) among other leadership roles in the cybersecurity industry.

“Over the years I’ve been involved with numerous companies and startups,” Andreassen shared. “However, it’s rare to see the channel community respond so overwhelmingly positively to a new technology as we’ve seen with PRE. I’m excited to be part of the team as we lead cybersecurity into the AI era.”

About PRE Security
PRE Security is redefining cybersecurity with its AI Native SecOps solutions, delivering advanced detection, predictive security analytics, and automation. Built on Generative, Predictive, and Agentic AI innovations, PRE Security eliminates the pain points and shortcomings of traditional SIEM and XDR solutions. Founded by cybersecurity veterans John “JP” Peterson and Paul Jespersen, PRE Security is headquartered in Silicon Valley.

Learn more at www.presecurity.ai.

Media Contact

Paul Jespersen
Email: [email protected]
Phone: 408-218-9668

SOURCE PRE Security

Investment signals strong confidence in Rep Data’s leadership, fueling investment in ground-breaking technology, expansion of tech-enabled research services and strengthening its position as the premier partner for high-quality research data.

NEW ORLEANS, March 13, 2025 — Rep Data, the industry’s leading provider of high-quality research data and fraud prevention solutions, today announced a growth investment by Mountaingate Capital. This will accelerate the company’s vision, strengthening its market-leading Research Desk and Research Defender platforms, while expanding its capabilities to better serve global brands, insight firms, and consultancies.

“This investment is a testament to the strength of our vision, our team, and the impact we are making in defining data quality for the market research industry,” said Patrick Stokes, CEO and founder of Rep Data. “From day one, we set out to raise the standard for research data integrity, and this growth investment enables us to push even further—advancing our fraud prevention technology, expanding our tech-enabled services, and ensuring that researchers worldwide can trust the data they collect. This marks an inflection point for Rep Data and the insights industry as a whole.”

Strengthening data integrity and efficiency in insights

Rep Data is an industry leader in data quality with its Research Defender platform, a sophisticated fraud detection technology designed to safeguard research integrity. The platform analyzes billions of data points annually, identifying and blocking fraudulent responses from tech-enabled fraudsters, professional survey takers, and click farms before they impact research studies. Research Defender processed 2.9 billion security scans in 2024, playing a pivotal role in shaping the industry’s fraud prevention standards and protecting research at an unprecedented scale.

Beyond fraud detection, Rep Data’s Research Desk platform improves speed to insights by integrating real-time fraud controls, multi-source sampling, and automated reconciliations into a seamless, centralized solution. By combining its expanding global sources with Research Defender’s fraud mitigation capabilities, Research Desk enhances data reliability, reduces inefficiencies, and strengthens research accuracy for clients.

Expanding service capabilities and strategic partnerships

By broadening its services and streamlining research execution, Rep Data is positioned to help clients move faster, reduce operational complexity, and drive more meaningful business outcomes with confidence in their data.

“We are extremely excited to partner with the Rep Data team. Rep Data is at the forefront of protecting research integrity with its cutting-edge Research Defender platform, setting a new standard for fraud prevention in the industry,” said Sue Cho, Managing Director of Mountaingate. “The company’s ability to analyze billions of data points and proactively eliminate fraudulent responses ensures that market researchers can rely on high-quality, trustworthy data. Rep Data’s rapid growth, innovative technology, commitment to data integrity, and impressive management team position it as a clear industry leader, with significant opportunities to further expand its impact and drive accelerated growth both organically and through strategic acquisitions.”

With this growth investment, Rep Data continues to advance the cause of data quality, efficiency, and execution; strengthening its position as a trusted partner, providing high-quality, reliable data for critical research studies.

Canaccord Genuity, a global investment bank, served as the exclusive advisor to Rep Data on this transaction. Jones Walker LLP represented Rep Data in the transaction and Morrison & Foerster LLP represented the buyer.

About Rep Data
Rep Data is a technology-driven data and insights partner, helping insights professionals streamline insights initiatives with a focus on data quality and consistent execution. Partnering with market research agencies, consultancies, Fortune 500 corporations, advertising and brand strategy firms, universities, and public relations agencies, Rep Data delivers real, reliable, and fraud-free research data at scale. Its solutions include: Research Desk, a centralized research platform that enhances efficiency and data quality; and Research Defender, an advanced fraud prevention system that conducts 2.9 billion security scans annually to protect data integrity. Through tech-enabled services, Rep Data provides expert support to help organizations scale with confidence. Committed to high-quality data and innovative tech-enabled solutions, Rep Data is redefining market research to drive faster, more reliable insights. For more information, visit www.repdata.com.

About Mountaingate Capital
Mountaingate Capital is a Colorado-based private equity firm that specializes in partnering with founders and entrepreneurial companies to accelerate growth and build industry leaders. Mountaingate’s focus on organic growth, coupled with its customer-centric buy-and-build approach for add-on acquisitions, and shared equity ownership with management, creates more value for the end customer, while forging stronger, more collaborative, and more successful investment partnerships with management teams. With over $1.4 billion of assets under management, Mountaingate targets investments in marketing services, business services, specialty manufacturing and distribution. For more information on Mountaingate, please visit www.mountaingate.com.

Media contact: Marie Melsheimer, [email protected], +1-541-815-3951

SOURCE Rep Data

The company will expand its state-of-the-art visual generative AI platform to bolster creation of scalable AI-driven visual products for enterprises without infringing on privacy or copyright.

NEW YORK, March 13, 2025 — Bria, the enterprise visual gen AI platform built on 100% licensed data, announced today that it has closed $40 million in Series B funding, bringing total capital raised to $65 million. Led by Red Dot Capital, with participation from Maor Investment, Entrée Capital, GFT Ventures, Intel Capital, and In-Venture, the investment will be used to scale the company’s visual generative AI platform, enabling enterprises to leverage the innovative technology risk-free to develop on-brand content. Bria will also use the funds to widen the application of its patented attribution engine beyond images to music, video, and text generation.

One of the most significant criticisms of AI today is its seeming lack of respect for existing IP and proper protocols for licensing. With this investment, Bria looks to change that, creating a whole new IP ecosystem wherein businesses can access licensed IP content from media conglomerates and studios for use in commercial gen AI creations, with built-in compliance. Bria’s Visual Generative AI platform empowers businesses to create predictable, controllable, and on-brand content that aligns with their visual language while supporting e-commerce use cases, identity preservation, and seamless content editing and fine-tuning.

“Since its inception, Bria’s mission has been to bridge the accountability gap between organizations and Gen AI through transparency, accessibility, and control,” said Dr. Yair Adato, Bria Founder and CEO. “While our patented attribution technology has instilled trust in AI systems, facilitating responsible, controlled access to coveted IP content will change the game. Enterprises can use our source code and API platform to integrate visual generative AI inside their products and access previously untouchable premium branded content. By broadening our attribution offering to all types of content, including music, video, and text, we are helping to usher in a truly sustainable creative economy.”

Bria’s Generative AI models are trained exclusively on licensed data, with built-in guardrails allowing enterprises to carve out the risks and barriers to Gen AI adoption and capitalize on infinite content creation. Bria developed a patented attribution engine that bridges the generative output and the training dataset, so data owners are programmatically compensated according to their overall influence on each generated output. Bria has over 30 data partners and is growing, including Getty Images, Envato, Alamy, Freepix, Depositphoto, and more. This Spotify-inspired commercial model ensures no copyright or privacy infringement and upholds transparency in line with evolving AI regulations.

Bria’s platform offers developers complete flexibility, including visual foundation models, source code and weights, and a fine-tuning API. It allows users to build wherever and whenever necessary to achieve their business goals. Bria integrates with AWS SageMaker, Azure AI Foundry, AI marketplaces, ComfyUI, Fal.AI, and more while offering plug-ins for Photoshop and Figma. Developers own their content machines, IP, and data wherever they build.

“The potential of generative AI in the enterprise space—where efficiency and creativity drive ROI—is immense,” said Danielle Ardon Baratz of Red Dot Capital. “Bria is redefining how enterprises create and personalize visual content at scale with its enterprise-grade platform, designed for control, predictability, and modularity. Bria is setting a new standard in AI-driven content generation. We are excited to support their journey as they help bring Gen AI to more organizations in a risk-free manner, how and where they want, while pioneering an innovative business model that keeps content creators compensated and incentivized”.

This round comes nearly one year after Bria closed its Series A funding in March 2024. Since then, Bria has solidified its position as a Responsible leader in AI-generated visual content through strategic alliances with technology giants, including Nvidia, Microsoft, and AWS. It was named an AWS Design Partner of the Year. Bria has also forged partnerships with global brands across high-growth sectors, such as media, gaming and entertainment, retail and CPG, marketing agencies, and creative tools.

About Bria

Bria’s visual generative AI platform enables developers, product teams, and enterprises to build commercial-ready content. Our foundation models, trained on 100% licensed data from 30+ partners, ensure legal compliance with proper attribution to data owners and artists.

Bria provides technical teams full access to source code and weights, production-grade APIs/SDKs, and the flexibility to incorporate these AI building blocks into their preferred builder environments. Bria’s pre-built pipelines offer the fastest path to market-ready visual AI implementation. At the same time, advanced teams leverage our ControlNets, LoRAs, and LCMs for pixel-perfect precision and maximum control over visual outputs. Bria offers complete IP/privacy indemnity and EU AI Act-compliant architecture with flexible commercial terms that leverage existing cloud commitments.

Leading advertising, gaming, media, and retail enterprises rely on Bria to deliver precise, on-brand visual content at scale. Looking ahead, Bria is pioneering the future of premium content generation—where visual AI, data ownership, and artistic contribution coexist to create sustainable value. For technical documentation, visit Bria.ai.

Media Contact

Sarah Small
Headline Media
[email protected]
IL:+972 052 214 8601
US:+1 929 255 1449
UK:+44 203 807 1858 

SOURCE Bria

PENNINGTON, N.J., March 12, 2025 — Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Illexcor Therapeutics (Illexcor), a pioneering biopharmaceutical company developing next-generation oral therapies for sickle cell disease (SCD). This investment underscores Zynext Ventures’ commitment to supporting disruptive healthcare innovations that address significant unmet medical needs.

Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD. Their lead asset, currently in preclinical development, is designed to bind to Hemoglobin S and effectively block polymerization and sickling, offering the potential for disease-modifying clinical benefits.

Speaking on the development, Dr. Sharvil Patel, MD of Zydus Lifesciences, said, “This investment reflects our commitment to patients battling rare and orphan diseases. Recognizing the profound impact of sickle cell disease on patients’ lives, we are pleased to support Illexcor in their efforts to develop a novel therapeutic solution addressing this critical unmet medical need.”

Emphasizing the strategic significance of the investment, Jay Kothari, Director of Zynext Ventures said, “This investment is consistent with Zynext Ventures’ objective of identifying and fostering transformative early-stage healthcare innovations. Beyond the financial backing, Zynext Ventures will leverage its unique data analytics and strategic expertise to accelerate Illexcor’s path to delivering this potentially life-changing therapy globally.”

Andrew Fleischman, CEO of Illexcor stated, “We are excited to partner with Zynext Ventures to advance our lead drug ILX002 into clinical trials later this year. We are hopeful that ILX002 will be a transformative treatment not only for SCD patients in the U.S. but also for millions around the globe. Zynext Ventures and Zydus Lifesciences are in a strategic position to help us achieve these goals.”

Sickle cell disease is a devastating and debilitating genetic condition that affects up to 10 million people worldwide. The disease continues to severely impact quality of life and longevity. Highly efficacious oral drug therapies are urgently needed to manage this condition on a global scale.

About Zynext Ventures

Zynext Ventures is the investment arm of Zydus Lifesciences. The venture capital firm focuses on identifying and investing in promising early-stage and growth-stage companies in the healthcare sector. Zynext Ventures provides financial support, strategic guidance, and industry expertise to its portfolio companies, helping them achieve their full potential and make a meaningful impact on the lives of patients.

To learn more about Zynext Ventures, please visit: https://zynextventures.com

LinkedIn:  Zynext Ventures

Twitter:  @ZynextVentures

About Zydus

Zydus Lifesciences Ltd. with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs 27,000 people worldwide, including 1,400 scientists engaged in R & D, and is driven by its mission to unlock new possibilities in lifesciences through quality healthcare solutions that impact lives. The group aspires to transform lives through path-breaking discoveries. Over the last decade, Zydus has introduced several innovative, first-in-class products in the market for treating unmet healthcare needs with vaccines, therapeutics, biologicals and biosimilars. For more details visit www.zyduslife.com.

About Illexcor

Illexcor Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative oral therapies for sickle cell disease. Their lead asset is a first-in-class drug designed to directly target the root cause of SCD, offering the potential for significant disease-modifying clinical benefits.

Logo – https://mma.prnewswire.com/media/2442038/Zynext_Ventures_Logo.jpg

SOURCE Zydus

Grant funding supports entrepreneurship programming, educational sessions across in-demand industries

INDIANAPOLIS, March 12, 2025 — Comcast today announced it has awarded a $37,500 grant to INvets, an Indianapolis-based non-profit that partners with veterans, their families, and communities to aid veterans transition to civilian life. Comcast’s grant supports INvet’s entrepreneurs’ program, in partnership with Venture Vets, which provides veterans and military spouses with digital skills for launching and growing successful businesses.

“Digital skills play an essential role in navigating our daily lives, and we’re honored to support INvets in their efforts to provide those skills to returning military members and their families,” said Craig D’Agostini, regional vice president of Government External and Government Affairs at Comcast. “Closing the digital skills gap means ensuring access to high-speed internet and access to digital literacy education for all Hoosiers.”

The 2024 grant will provide veterans and their families with educational sessions on financial management systems, digital marketing, data analytics, cybersecurity, and artificial intelligence. The grant will also support guest speakers, and a technology upgrade stipend to enable participants to utilize software from their learned systems. 

“Helping veterans transition to civilian life means providing them and their families with what they need to find meaningful employment to succeed and thrive in the communities they live,” said Sarah Harrison, CEO, INvets. “Comcast’s support will enable veterans we work with to learn critical digital skills, while ultimately strengthening Indiana’s economy.” 

This grant is a part of Project UP, Comcast’s $1 billion commitment to providing digital opportunity and advancing economic mobility. Comcast partners with local community organizations to offer free Internet access via Lift Zones and support vital programs, which provide participants with digital literacy training and digital navigation services to expand their world with unlimited possibilities.

About INvets 
INvets is a nonprofit organization, founded by and run by veterans, dedicated to recruiting transitioning service members and their families from almost 40 military installations around the country, to Indiana.

INvets understands that transitioning from the military is not one person starting a new career, it is a life change for the whole family and potentially comes with a lot of stress. We work with over 600 corporate partners to match these transitioning military with high wage, high demand civilian careers, or apprenticeship programs for skilled trades that allow you to earn while you learn.

INvets will work to match your families’ preferred lifestyles, needs, and wants, to communities in Indiana for you to call home.

The wrap around services INvets provides include reviewing and building your resumes, providing access to Happy LLC., to manage the stressors of transition, and we share the benefits Indiana offers to veterans. For example, no tax on military pensions, reserve, or guard pay, reductions in property tax and educational benefits to name a few.

INvets will meet you and your family where you are, by connecting you with a Veteran Engagement Manager who will collaborate with you for as long as you need, in order to get settled in your new civilian chapter in life. All for no cost.

About Comcast Corporation
Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company. From the connectivity and platforms we provide, to the content and experiences we create, our businesses reach hundreds of millions of customers, viewers, and guests worldwide. We deliver world-class broadband, wireless, and video through Xfinity, Comcast Business, and Sky; produce, distribute, and stream leading entertainment, sports, and news through brands including NBC, Telemundo, Universal, Peacock, and Sky; and bring incredible theme parks and attractions to life through Universal Destinations & Experiences. Visit www.comcastcorporation.com for more information.

About Comcast Indiana
With more than 1,100 local employees, Comcast Indiana (https://indiana.comcast.com/) has served customers in Indiana for more than four decades. In the last three years, we’ve invested more than $1.3 billion in Indiana, including capital expenditures, employee wages and benefits, taxes, charitable giving, and infrastructure upgrades. “Like” Comcast Indiana on Facebook by visiting @Comcast. “Follow” Comcast Indiana on X at @ComcastIN.

Press Contacts
Amy Pietzak
248-318-8905
[email protected]

Samantha VanHoef
734-478-7118
[email protected] 

SOURCE Comcast

Former 2U Chief Revenue Officer Receives Backing from Ardent Venture Partners to Develop Go-To-Market Technology Using AI Agents

WASHINGTON, March 12, 2025 — After a year in stealth, e:cue officially launches today with funding from Ardent Venture Partners, bringing AI Agents to power data science for go-to-market (GTM) business leaders. Founded by Harsha Mokkarala, former Chief Revenue Officer and Chief Data Scientist of 2U, Inc and senior executive at Capital One, e:cue is building the next generation of AI-driven intelligence for marketing and sales teams—helping organizations move beyond static data analysis to proactive, AI-driven decision-making.

Solving a Trillion-Dollar Business Intelligence Problem
Businesses are drowning in data, but most can’t extract real-world value from it. According to IBM, poor data quality costs businesses in the U.S. more than $3.1 trillion annually. e:cue is addressing these data challenges by embedding AI-driven data science directly into existing workflows, enabling leaders to anticipate challenges, identify opportunities, and take immediate action.

“Businesses don’t need more dashboards; they need the ability to trust and interpret their data,” said Harsha Mokkarala, Founder and CEO of e:cue. “This is an expensive and slow process that hinders their ability to find growth in today’s dynamic marketplaces. We are building e:cue to move beyond reporting—our AI Agent, Cue™, embeds actionable data science into the organization’s existing workflows, helping leaders make informed decisions with speed and confidence.”

A Proven Leader in Data-Driven Revenue Strategy
Mokkarala, formerly Chief Revenue Officer and Chief Marketing Officer at 2U and a senior executive at Capital One, has spent his career at the intersection of data, technology, and business strategy. At 2U, he led the company’s tenfold revenue growth and scaled digital education programs for top-tier universities. At Capital One, he helped spearhead the transition from traditional marketing to digital marketing powered by predictive analytics, redefining how the company engaged customers.

The First GTM-Specific Data Science Solution Using AI Agents
e:cue is pioneering agentic AI in the GTM business intelligence arena, an unexplored space representing a massive opportunity for transformation. A key part of this solution is Cue™, a custom AI agent that helps businesses monitor performance, predict outcomes, and confidently devise next steps. Cue is an embedded data analyst that helps automate critical analytical workflows, integrate them into existing tools and access them using natural language.

“While many businesses use generative AI in their marketing and sales operations, few tap into agentic AI to shape business strategy.” added Mokkarala. “Cue helps leaders move from reactive decision-making to proactively shaping GTM strategies.”

Investor Confidence in e:cue’s Vision
Backed by Ardent Venture Partners (AVP), e:cue is positioned to redefine AI-powered business intelligence. Phil Bronner, Managing Partner at AVP, sees e:cue’s approach as a game-changer for modern enterprises.

“Businesses generate vast amounts of data, but without data science, they struggle to turn it into a competitive advantage,” said Bronner. “e:cue is bridging that gap, using AI to enable actionable data science at scale for organizations of all types and sizes. We’re excited to support Harsha and the e:cue team as they transform how organizations operate.”

With strong early traction, investment from AVP, and a bold vision for the future of AI-powered decision-making, e:cue is set to become the go-to intelligence platform for business leaders looking to drive strategic growth.

About e:cue AI

e:cue AI is designed to be the last business intelligence solution you’ll ever need. Powered by real data science and advanced AI agents, e:cue AI reaches across a company’s entire data ecosystem, connecting fragmented information to build the most complete business picture. Instead of static dashboards and overwhelming spreadsheets, e:cue AI delivers actionable insights—right on Cue™. https://www.ecue.ai/

About Ardent Venture Partners

Ardent Venture Partners (AVP) is an early-stage, thesis-driven venture capital firm specializing in vertical SaaS, AI-native software applications, and B2B fintech. The firm has cultivated a portfolio that includes promising companies like Method Financial, Givebutter, Crux Climate, Collective, and Rainforest, each aiming to redefine their respective categories. For further details on AVP’s mission and portfolio, visit https://www.ardent.vc/.

Media Contact:

Jordan Valdés
202-643-4467
[email protected]
www.varnumstreetstrategies.com

SOURCE e:cue

New capital will accelerate technology development, scale operations, and strengthen customer partnerships.

ATLANTA, March 12, 2025 — Carpool Logistics, the leading vehicle logistics platform, announced that it has raised $12 million in Series A growth capital led by Wavecrest Growth Partners, with participation from CarMax, Impel founders Devin Daly and Michael Quigley, as well as automotive industry veteran David Metter. The new funding will be strategically deployed to accelerate Carpool’s growth across multiple fronts: enhancing the technology platform, expanding product development, optimizing logistics capabilities, and scaling sales and marketing efforts to drive customer acquisition and market expansion.

“We do more than just ship cars; everything we do is focused on improving the customer experience and making shipping a competitive advantage for our clients. Our platform bundles multiple vehicles into one shipment to reduce turnaround times and costs, while our white-glove approach – with real-time tracking and robust security measures – mitigates risks like damage claims and fraud,” said Mike Malakhov, Founder and CEO of Carpool Logistics. “The funding from Wavecrest and CarMax allows us to scale more effectively, strengthen our team, and enhance our technology. By serving as a trusted partner to our customers and seamlessly integrating the Carpool platform with their workflows, we help our clients stay ahead in an increasingly competitive market.”

Founded in 2021, Carpool Logistics has become one of the fastest growing vehicle shipping platforms. By leveraging advanced technology, the company optimizes vehicle shipping, resulting in cost savings and reduced environmental impact. Since its inception, Carpool has expanded its customer base to over 1,800 clients, including auto auctions, dealerships, manufacturers, and fleets, and has shipped more than 150,000 vehicles. Previously, the company raised a $3.5 million seed round from Atlanta Ventures and Overline Ventures in 2022.

“The vehicle logistics industry is rapidly evolving, and Carpool is at the forefront of this transformation,” said Deepak Sindwani, Managing Partner at Wavecrest Growth Partners. “Our firm and extended team have a long history investing in the automotive industry, and Carpool’s purpose-built technology platform and marketplace and uniquely experienced leadership team are clearly differentiated. We believe Carpool is well-positioned to become the category leader, and we are excited to partner with them to accelerate their next phase of growth.”

“We’re proud to partner with Wavecrest and CarMax to accelerate our growth and further invest in our team and technology. Wavecrest’s experience in scaling technology-driven businesses will help us optimize operations and expand our market reach, while CarMax’s deep industry expertise and expansive network provide invaluable insights into large-scale vehicle distribution. With their support, we’re well positioned to digitize vehicle logistics and drive greater efficiency for our customers,” said Malakhov.

ABOUT CARPOOL LOGISTICS

Carpool Logistics, based in Atlanta, Georgia, is a vehicle shipping marketplace fueled by their cutting-edge technology platform. By seamlessly connecting auto haulers with shippers – including auto auctions, dealerships, manufacturers, and fleets – the company streamlines logistics, lowers costs, and reduces emissions. A member of the Atlanta Tech Village and graduate of the Georgia Tech Advanced Technology Development Center (ATDC), Carpool Logistics has earned recognition as a leading innovator in the Southeast, being named Atlanta’s Best B2B Startup and a 2024 Top 40 Innovative Company in Georgia. Learn more at carpoollogistics.com.

ABOUT WAVECREST GROWTH PARTNERS

Wavecrest Growth Partners is a growth equity firm focused on investing in and partnering with leading B2B software and technology-enabled services companies based in both North America and Western Europe. Wavecrest targets investments in high-growth companies with proven products and business models and brings to bear a differentiated combination of investing and operating experience and networks to help accelerate growth and profitability. Wavecrest’s team has over five decades of collective investing and operating experience in growth-stage B2B technology companies, including numerous successful outcomes. For more information, visit wavecrestgrowth.com.

ABOUT CARMAX

CarMax, the nation’s largest retailer of used autos, revolutionized the automotive retail industry by driving integrity, honesty and transparency in every interaction. The company offers a truly personalized experience with the option for customers to do as much, or as little, online and in-store as they want. During the fiscal year that ended February 29, 2024, CarMax sold approximately 770,000 used vehicles and 550,000 wholesale vehicles at its auctions. In addition, CarMax Auto Finance originated more than $8 billion in receivables during fiscal 2024, adding to its more than $17 billion portfolio. CarMax has over 245 store locations, nearly 30,000 associates, and is proud to have been recognized for 20 consecutive years as one of the Fortune 100 Best Companies to Work For®. CarMax is committed to making a positive impact on people, communities and the environment. Learn more in the 2024 Responsibility Report. For more information, visit www.carmax.com.

CONTACT

Austin Bryan
[email protected]

SOURCE Carpool Logistics